Oral Answers to Questions

Stephen Hammond Excerpts

Tuesday 21st October 2014 Commons Chamber

[George Freeman]

I will happily meet the BMA, but such a request is a bit rich coming from a Labour party that legislated to introduce competition in the health service and to pay private sector providers 11% more, which is now illegal under the Health and Social Care Act 2012. Let me be clear about this, and I can be no clearer than the Labour member of the all-party group for TTIP, who said that

“my direct discussions with the EU’s chief negotiator have helped produce an EU promise to fully protect our health service…TTIP could have no impact on the UK’s sovereign right to make changes to the NHS.”

[Stephen Hammond (Wimbledon) (Con)]

I am grateful to the Minister for confirming that these negotiations will have no effect on NHS services and how they are provided. With his life sciences hat on, will the Minister also confirm that this treaty gives us a real advantage as UK companies will be able to compete in the American market?

[George Freeman]

My hon. Friend makes an excellent point. As well as providing a £10 billion boost to the economy, which I am surprised to see that the left is not in favour of, and securing 13 million jobs in the EU, this treaty also helps our NHS pioneers and innovators and our UK life science companies generate revenue for this country from our innovations in health care in the world’s biggest health care market.

Oral Answers to Questions

Stephen Hammond Excerpts

Tuesday 7th June 2011 Commons Chamber

[Andrew Stephenson (Pendle) (Con)]

11. What recent representations he has received on the operation of the cancer drugs fund.

[Stephen Hammond (Wimbledon) (Con)]

16. What recent assessment he has made of the operation of the cancer drugs fund; and if he will make a statement.

[The Secretary of State for Health (Mr Andrew Lansley)]

I have received representations from hon. Members, noble Lords and members of the public on how the fund has operated. A number have welcomed the additional support that we are giving to cancer patients in need. More than 2,500 patients have already benefited from the additional funding provided up to the start of April 2011, and the further £600 million that we have committed for next three years will improve the lives of thousands more cancer sufferers.

[Mr Lansley]

Yes, I can reassure my hon. Friend on that point. Indeed, I cannot do better than to quote Mike Hobday, head of policy at Macmillan Cancer Support, who said:

“The £200 million Cancer Drugs Fund will make sure every cancer patient has a better chance to get the drugs their doctor prescribes for them. This is particularly important for those with a rarer cancer, who have historically lost out on getting drugs on the NHS.”

[Stephen Hammond]

I am sure the whole House will welcome my right hon. Friend’s announcement today that 2,500 people have already benefited from the interim cancer drugs fund. Can he give the House some indication of whether people with the more difficult types of cancer will benefit from it?